Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Price:
12.64
USD
7.03%
Market Cap:
$996m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
|
US |
|
S
|
Shibuya Corp
TSE:6340
|
JP |
|
W
|
Wetzel SA
BOVESPA:MWET4
|
BR |
|
Nissin Electric Co Ltd
TSE:6641
|
JP |
|
Creative Technology Ltd
SGX:C76
|
SG |
|
Creative Media & Community Trust Corporation
NASDAQ:CMCT
|
US |
|
T
|
Thua Thien Hue Construction Joint Stock Corp
VN:HUB
|
VN |
|
Cardinal Energy Ltd (Alberta)
F:C0Y
|
CA |
|
Brookfield Renewable Partners LP
TSX:BEP.UN
|
BM |
|
First Robinson Financial Cororation
OTC:FRFC
|
US |
|
Makuake Inc
TSE:4479
|
JP |
|
M
|
MetaLabs Co Ltd
KRX:090370
|
KR |
Balance Sheet
Balance Sheet Decomposition
Phathom Pharmaceuticals Inc
Phathom Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
Phathom Pharmaceuticals Inc
Phathom Pharmaceuticals Inc
Balance Sheet
Phathom Pharmaceuticals Inc
Phathom Pharmaceuticals Inc
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
1
|
244
|
288
|
183
|
155
|
381
|
297
|
130
|
|
| Cash Equivalents |
1
|
244
|
288
|
183
|
155
|
381
|
297
|
130
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
2
|
39
|
78
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
2
|
39
|
78
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
1
|
3
|
6
|
|
| Other Current Assets |
0
|
12
|
4
|
3
|
5
|
13
|
21
|
15
|
|
| Total Current Assets |
1
|
256
|
291
|
187
|
161
|
397
|
360
|
229
|
|
| PP&E Net |
0
|
1
|
3
|
3
|
4
|
4
|
2
|
4
|
|
| PP&E Gross |
0
|
1
|
3
|
3
|
4
|
4
|
2
|
4
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
2
|
2
|
3
|
3
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
13
|
16
|
27
|
|
| Total Assets |
1
N/A
|
257
+28 478%
|
295
+15%
|
189
-36%
|
165
-13%
|
414
+151%
|
378
-9%
|
259
-31%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
1
|
17
|
5
|
10
|
13
|
11
|
5
|
|
| Accrued Liabilities |
0
|
3
|
31
|
14
|
16
|
19
|
55
|
92
|
|
| Short-Term Debt |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
7
|
0
|
0
|
7
|
20
|
27
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
|
| Total Current Liabilities |
2
|
4
|
56
|
19
|
26
|
39
|
86
|
132
|
|
| Long-Term Debt |
0
|
23
|
40
|
90
|
205
|
438
|
535
|
559
|
|
| Other Liabilities |
0
|
3
|
6
|
9
|
9
|
10
|
12
|
6
|
|
| Total Liabilities |
2
N/A
|
29
+1 227%
|
101
+245%
|
117
+16%
|
240
+104%
|
487
+103%
|
632
+30%
|
697
+10%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1
|
256
|
386
|
529
|
727
|
929
|
1 263
|
1 484
|
|
| Additional Paid In Capital |
0
|
484
|
580
|
602
|
652
|
856
|
1 009
|
1 046
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
228
N/A
|
194
-15%
|
72
-63%
|
75
N/A
|
73
+3%
|
254
-249%
|
438
-73%
|
|
| Total Liabilities & Equity |
1
N/A
|
257
+28 478%
|
295
+15%
|
189
-36%
|
165
-13%
|
414
+151%
|
378
-9%
|
259
-31%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
26
|
25
|
29
|
31
|
42
|
58
|
69
|
71
|
|
Switch to:
Switch to:
See Also
Discover More
